Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Sell
21,415
-47
-0.2% -$5.43K 1.08% 22
2025
Q4
$2.26M Buy
21,462
+1,362
+7% +$128K 0.92% 23
2025
Q3
$1.69M Buy
20,100
+1,284
+7% +$106K 0.7% 33
2025
Q2
$1.49M Buy
18,816
+188
+1% +$14.9K 0.71% 33
2025
Q1
$1.67M Sell
18,628
-1,025
-5% -$95.7K 0.85% 28
2024
Q4
$1.96M Buy
19,653
+293
+2% +$30.2K 0.91% 25
2024
Q3
$2.2M Sell
19,360
-875
-4% -$104K 1.02% 22
2024
Q2
$2.51M Sell
20,235
-1,586
-7% -$204K 1.21% 17
2024
Q1
$2.88M Sell
21,821
-1,058
-5% -$130K 1.4% 12
2023
Q4
$2.49M Sell
22,879
-692
-3% -$71.8K 1.34% 13
2023
Q3
$2.43M Buy
23,571
+149
+0.6% +$16.1K 1.43% 13
2023
Q2
$2.7M Sell
23,422
-2,423
-9% -$275K 1.59% 12
2023
Q1
$2.75M Buy
25,845
+812
+3% +$87.7K 1.67% 10
2022
Q4
$2.78M Sell
25,033
-2,240
-8% -$229K 1.74% 10
2022
Q3
$2.35M Sell
27,273
-283
-1% -$25.3K 1.59% 11
2022
Q2
$2.51M Buy
27,556
+88
+0.3% +$7.8K 1.62% 11
2022
Q1
$2.25M Buy
27,468
+809
+3% +$63.8K 1.26% 14
2021
Q4
$2.04M Sell
26,659
-109
-0.4% -$8.68K 1.12% 20
2021
Q3
$2.01M Buy
26,768
+1,906
+8% +$145K 1.21% 18
2021
Q2
$1.93M Buy
24,862
+2,269
+10% +$169K 1.21% 16
2021
Q1
$1.66M Buy
22,593
+5,057
+29% +$373K 1.15% 20
2020
Q4
$1.37M Buy
17,536
+2,135
+14% +$163K 1.03% 22
2020
Q3
$1.22M Buy
15,401
+1,099
+8% +$86.1K 1.03% 23
2020
Q2
$1.05M Buy
14,302
+1,553
+12% +$117K 0.93% 27
2020
Q1
$936K Buy
12,749
+2,027
+19% +$159K 1.01% 24
2019
Q4
$931K Buy
10,722
+1,082
+11% +$88.9K 0.79% 33
2019
Q3
$774K Buy
9,640
+982
+11% +$78.7K 0.72% 40
2019
Q2
$693K Buy
8,658
+1,525
+21% +$117K 0.59% 50
2019
Q1
$566K Buy
7,133
+412
+6% +$30.8K 0.29% 65
2018
Q4
$490K Buy
6,721
+850
+14% +$60K 0.31% 62
2018
Q3
$397K Sell
5,871
-471
-7% -$30K 0.23% 77
2018
Q2
$367K Sell
6,342
-724
-10% -$40.8K 0.21% 80
2018
Q1
$367K Sell
7,066
-419
-6% -$22.6K 0.21% 81
2017
Q4
$402K Buy
+7,485
New +$415K 0.24% 67

Other funds holding MRK

CNB Bank's MRK Position: Q1 2026 in Review

CNB Bank reduced its Merck (MRK) stake by 0.22% in Q1 2026, selling an estimated $5.43K and leaving 21,415 shares worth $2.58M. The position accounts for 1.08% of the portfolio, ranked #22.

CNB Bank first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.88M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • CNB Bank held 21,415 shares of Merck worth $2.58M as of Q1 2026.
  • CNB Bank sold 47 Merck shares in Q1 2026, an estimated $5.43K.
  • Merck made up 1.08% of CNB Bank's portfolio in Q1 2026, its #22 holding.
  • CNB Bank first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
  • CNB Bank's Merck position peaked at $2.88M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.